![Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/14/2/278/F2.large.jpg)
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology
![Dabigatran, intracranial hemorrhage, and the neurosurgeon in: Neurosurgical Focus Volume 34 Issue 5 (2013) Dabigatran, intracranial hemorrhage, and the neurosurgeon in: Neurosurgical Focus Volume 34 Issue 5 (2013)](https://thejns.org/focus/view/journals/neurosurg-focus/34/5/0340007f1.jpg)
Dabigatran, intracranial hemorrhage, and the neurosurgeon in: Neurosurgical Focus Volume 34 Issue 5 (2013)
![Figure 2 from Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants | Semantic Scholar Figure 2 from Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3c7f499e2b7930593a5098ae167815ccf0c1b055/4-Figure2-1.png)
Figure 2 from Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants | Semantic Scholar
![Nutrients | Free Full-Text | New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) | HTML Nutrients | Free Full-Text | New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) | HTML](https://www.mdpi.com/nutrients/nutrients-07-05479/article_deploy/html/images/nutrients-07-05479-g001.png)
Nutrients | Free Full-Text | New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) | HTML
![Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. - Abstract - Europe PMC Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3550194/bin/13181_2011_178_Fig1_HTML.jpg)
Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. - Abstract - Europe PMC
![Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram](https://www.researchgate.net/profile/Irene-Predazzi/publication/236090583/figure/fig1/AS:601591971315727@1520442111483/Mechanism-of-action-of-warfarin-dabigatran-rivaroxaban-and-apixaban-in-relation-to-the.png)
Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram
![Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. - Abstract - Europe PMC Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3550194/bin/13181_2011_178_Fig2_HTML.jpg)